257 related articles for article (PubMed ID: 33426698)
41. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
42. Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma.
Acharya S; Rai P; Hallikeri K; Anehosur V; Kale J
J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27157628
[TBL] [Abstract][Full Text] [Related]
43. Value of Preoperative Hematological Parameters in the Prognosis of Gastric Cancer Patients Undergoing a Total Gastrectomy.
Zhu XS; Zhao Y; Ma FY; Wu SK
Curr Med Sci; 2022 Apr; 42(2):348-356. PubMed ID: 35419673
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract][Full Text] [Related]
45. Prognostic role of an inflammation scoring system in radical resection of oral squamous cell carcinoma.
Wu M; Ye P; Zhang W; Zhu H; Yu H
BMC Oral Health; 2022 Jun; 22(1):226. PubMed ID: 35676658
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system.
Lee S; Kim DW; Kwon S; Kim HJ; Cha IH; Nam W
Sci Rep; 2020 Jul; 10(1):12111. PubMed ID: 32694586
[TBL] [Abstract][Full Text] [Related]
47. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
48. A New Index AGR-PLR Score (APS) for Patients with Esophageal Squamous Cell Carcinoma Undergoing Radical Esophagectomy.
Yao Y; Cai C; Sun F; Gong W
Cancer Manag Res; 2021; 13():6129-6139. PubMed ID: 34385842
[TBL] [Abstract][Full Text] [Related]
49. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
Valero C; Zanoni DK; McGill MR; Ganly I; Morris LGT; Quer M; Shah JP; Wong RJ; León X; Patel SG
Cancer; 2020 Mar; 126(5):994-1003. PubMed ID: 31809562
[TBL] [Abstract][Full Text] [Related]
50. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.
Yanni A; Buset T; Bouland C; Loeb I; Lechien JR; Rodriguez A; Journe F; Saussez S; Dequanter D
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4103-4111. PubMed ID: 35099595
[TBL] [Abstract][Full Text] [Related]
51. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
52. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
53. Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic Prostate Cancer.
Salciccia S; Frisenda M; Bevilacqua G; Viscuso P; Casale P; De Berardinis E; Di Pierro GB; Cattarino S; Giorgino G; Rosati D; Del Giudice F; Carbone A; Pastore A; Chung BI; Eisenberg ML; Autorino R; Crivellaro S; Forte F; Sciarra A; Mariotti G; Gentilucci A
Curr Oncol; 2022 Dec; 29(12):9474-9500. PubMed ID: 36547159
[TBL] [Abstract][Full Text] [Related]
54. The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.
Wang T; Lin H; Hsueh C; Lau HC; Zhou J; Gong H; Tao L; Zhou L; Wu C
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):453-463. PubMed ID: 35709701
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
56. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
57. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
[TBL] [Abstract][Full Text] [Related]
58. High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer.
Perisanidis C; Kornek G; Pöschl PW; Holzinger D; Pirklbauer K; Schopper C; Ewers R
Med Oncol; 2013 Mar; 30(1):334. PubMed ID: 23292862
[TBL] [Abstract][Full Text] [Related]
59. Are Comorbidities Associated With Overall Survival in Patients With Oral Squamous Cell Carcinoma?
Jariod-Ferrer ÚM; Arbones-Mainar JM; Gavin-Clavero MA; Simón-Sanz MV; Moral-Saez I; Cisneros-Gimeno AI; Martinez-Trufero J
J Oral Maxillofac Surg; 2019 Sep; 77(9):1906-1914. PubMed ID: 30980811
[TBL] [Abstract][Full Text] [Related]
60. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer.
Yu L; Jiang R; Chen W; Liu Y; Wang G; Gong X; Wang Y
World J Surg Oncol; 2023 Feb; 21(1):50. PubMed ID: 36803398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
